Načítá se...
Engineering Challenges for Brain Tumor Immunotherapy
Malignant brain tumors represent one of the most devastating forms of cancer with abject survival rates that have not changed in the past 60 years. This is partly because the brain is a critical organ, and poses unique anatomical, physiological, and immunological barriers. The unique interplay of th...
Uloženo v:
| Vydáno v: | Adv Drug Deliv Rev |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5870902/ https://ncbi.nlm.nih.gov/pubmed/28625831 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.addr.2017.06.006 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|